Atorvastatin regulates apoptosis in chronically ischemic myocardium.


Journal Article

We previously demonstrated that atorvastatin upregulates proangiogenic proteins and increases arteriolar density in ischemic myocardium. Despite this, there was a lack of collateral-dependent perfusion, possibly related to apoptosis. We utilized a swine model of metabolic syndrome and chronic myocardial ischemia to investigate the effects of atorvastatin on apoptosis.Sixteen Ossabaw miniswine were fed a high-cholesterol diet for 14 weeks then underwent surgical placement of an ameroid constrictor to their circumflex artery inducing chronic ischemia. Eight pigs additionally received supplemental atorvastatin (1.5 mg/kg daily). Myocardium was harvested six months later for western blotting and TUNEL staining.Animals supplemented with atorvastatin had significant increases in markers associated with apoptosis including p-38, BAX, and caspase 3 (p < 0.05). Atorvastatin supplementation also resulted in significant increases in expression of cell survival proteins Bcl-2 and P-ERK and an overall decrease in apoptosis demonstrated by TUNEL staining (p < 0.05).Atorvastatin acts on multiple pathways and its effects on angiogenesis remain unclear. Although there is increased expression in several markers of apoptosis, key anti-apoptotic proteins were also upregulated with an overall decrease in apoptosis. Further investigation of these pathways may provide insight into the role of statins on myocardial protection after ischemia.

Full Text

Cited Authors

  • Sabe, AA; Elmadhun, NY; Sadek, AA; Dalal, RS; Chu, LM; Bianchi, C; Sellke, FW

Published Date

  • February 2015

Published In

Volume / Issue

  • 30 / 2

Start / End Page

  • 218 - 223

PubMed ID

  • 25511504

Pubmed Central ID

  • 25511504

Electronic International Standard Serial Number (EISSN)

  • 1540-8191

International Standard Serial Number (ISSN)

  • 0886-0440

Digital Object Identifier (DOI)

  • 10.1111/jocs.12488


  • eng